Sequenta Receives $20,000,000 Series C Financing

  • Feed Type
  • Date
    7/2/2013
  • Company Name
    Sequenta
  • Mailing Address
    400 East Jamie Court South San Francisco, CA 94080
  • Company Description
    Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
  • Website
    http://www.sequentainc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Sequenta will use the financing proceeds for commercial scale up and clinical validation of the ClonoSIGHT test.
  • M&A Terms
  • Venture Investor
    Foresite Capital
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Index Ventures

By posting a comment, you agree to our terms and conditions.